 STRATA Skin Sciences Inc NASDAQ: SSKN expects Q4 FY21 sales of 8.8 million - 9.2 million, compared to 6.7 million in Q4 FY20 and the consensus of 8.19 million. For FY21, it expects sales of 29.7 million - 30.1 million compared to a consensus of 29.11 million, up from 23.1 million in FY20. 